| Tolerability Study of Panosyl-Isomaltooligosaccharides (PIMO) and a Placebo in Subjects With Heartburn (NCT05363618) | Microbiome Health Sciences | 2022-02-10 |
| A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) (NCT05195528) | Phathom Pharmaceuticals, Inc. | 2022-01-17 |
| Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers (NCT06552624) | Valenta Pharm JSC | 2021-07-07 |
| A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NCT04799158) | Phathom Pharmaceuticals, Inc. | 2021-03-25 |
| Implementation of a Minor Ailment Service in Community Pharmacy Practice (NCT05247333) | Universidad de Granada | 2020-10-01 |
| Remote Guided Caffeine Reduction (NCT04560595) | Johns Hopkins University | 2020-09-10 |
| Study of Dietary Patterns and Food Diversity in Russian GERD Patients (NCT04252144) | Russian Academy of Medical Sciences | 2020-01-30 |
| Fermented Soy and Heartburn Symptom Relief (NCT03867591) | University of Florida | 2019-03-22 |
| Mipolixin® Compared to Poliprotect® in Moderate Functional Dyspepsia and Heartburn. (NCT03531372) | Aboca Spa Societa' Agricola | 2018-04-24 |
| Bile Reflux Gastropathy: Prevalence and Risk Factors After Therapeutic Biliary Interventions (NCT05131802) | Zagazig University | 2018-01-01 |
| Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients (NCT02873689) | Takeda | 2016-12-27 |
| Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment (NCT02708355) | Pfizer | 2016-01-01 |
| Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy (NCT02105090) | Helsinki University Central Hospital | 2014-10-01 |
| Symptom Control Satisfaction With Proton Pump Inhibitor Regimen (NCT02623816) | MetroHealth Medical Center | 2014-08-01 |
| Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets (NCT02096458) | Takeda | 2014-02-01 |
| Response to Supplement and Placebo in GERD (NCT01915173) | Beth Israel Deaconess Medical Center | 2013-06-01 |
| Domperidone in Treating Patients With Gastrointestinal Disorders (NCT01696734) | M.D. Anderson Cancer Center | 2012-10-23 |
| Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036) (NCT01587885) | Bayer | 2012-01-01 |
| Efficacy of Esomeprazole in Patients With Frequent Heartburn (NCT01370538) | AstraZeneca | 2011-08-01 |
| Efficacy of Esomeprazole in Patients With Frequent Heartburn (NCT01370525) | AstraZeneca | 2011-08-01 |
| Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD) (NCT01199679) | Cook Group Incorporated | 2011-06-01 |
| A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12) (NCT01337804) | Bayer | 2011-01-01 |
| To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole (NCT01249651) | AstraZeneca | 2010-11-01 |
| Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease (NCT01338077) | Chang Gung Memorial Hospital | 2010-10-01 |
| Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo (NCT00481949) | Guy's and St Thomas' NHS Foundation Trust | 2010-09-01 |
| Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn (NCT01149395) | University of North Carolina, Chapel Hill | 2010-06-01 |
| Do Acid Sensing Ion Channels Contribute to Heartburn? (NCT01095133) | University of North Carolina, Chapel Hill | 2010-03-01 |
| Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn (NCT01037452) | Novartis | 2009-12-01 |
| Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI (NCT01005251) | AstraZeneca | 2009-10-01 |
| Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD) (NCT00842387) | AstraZeneca | 2009-01-01 |
| Confocal Laser Microscopy in Non Erosive Reflux Disease (NCT00588939) | Mayo Clinic | 2008-11-01 |
| Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms (NCT00703534) | AstraZeneca | 2008-05-01 |
| A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED) (NCT00944671) | Johnson & Johnson Consumer and Personal Products Worldwide | 2008-02-01 |
| What is the Predictive Value of the Reflux Impact Scale (NCT00536328) | AstraZeneca | 2007-10-01 |
| Efficacy and Safety of Itopride vs Placebo in Heartburn (NCT00382577) | Forest Laboratories | 2006-10-01 |
| A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144) (NCT00945750) | Merck Sharp & Dohme LLC | 2006-08-01 |
| Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD) (NCT00373334) | Braintree Laboratories | 2006-08-01 |
| Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn (NCT00390390) | Novartis | 2006-06-01 |
| Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn (NCT00389948) | Novartis | 2006-06-01 |
| Esomeprazole and Gastric Emptying of Beer (NCT00472550) | Heidelberg University | 2006-01-01 |
| Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage (NCT00524329) | AstraZeneca | 2006-01-01 |
| E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers (NCT00236197) | Eisai Inc. | 2005-10-01 |
| E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers (NCT00236184) | Eisai Inc. | 2005-10-01 |
| HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease (NCT00243724) | AstraZeneca | 2005-04-01 |
| The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia. (NCT00171457) | Novartis | 2005-04-01 |
| Acid-Associated Heartburn Symptoms and Dose of Esomeprazole (NCT00206024) | AstraZeneca | 2004-11-01 |
| Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms. (NCT00553449) | Janssen-Ortho Inc., Canada | 2004-07-01 |
| A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients (NCT00625274) | AstraZeneca | 2004-06-01 |
| Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule (NCT00579410) | VA Office of Research and Development | 2004-05-01 |
| Questionnaire to Assess Gastrointestinal Symptoms of Oral Iron. (NCT02146053) | Medical Research Council | 2004-03-01 |
| Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes (NCT01928888) | Bayer | 2003-05-01 |
| A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) (NCT00216489) | Janssen Cilag Pharmaceutica S.A.C.I., Greece | 2003-03-01 |
| Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD) (NCT00637845) | AstraZeneca | 2002-06-01 |
| A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD) (NCT00236392) | Janssen Pharmaceutica N.V., Belgium | 2001-10-01 |
| A Comparison of Factors of Symptoms Generation and Evaluation of Role of Biofeedback in Patients With Different Types of Functional Esophageal Disorders (Functional Heartburn and Functional Chest Pain) (NCT00471796) | Assaf-Harofeh Medical Center | |